ELI-002 7P
ELI-002-201
Phase 2 small_molecule active
Quick answer
ELI-002 7P for Pancreatic Ductal Adenocarcinoma is a Phase 2 program (small_molecule) at Elicio Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Elicio Therapeutics
- Indication
- Pancreatic Ductal Adenocarcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active